GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Atara Biotherapeutics Inc (LTS:0HIY) » Definitions » Cyclically Adjusted PB Ratio

Atara Biotherapeutics (LTS:0HIY) Cyclically Adjusted PB Ratio : 0.09 (As of May. 18, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Atara Biotherapeutics Cyclically Adjusted PB Ratio?

As of today (2024-05-18), Atara Biotherapeutics's current share price is $0.62. Atara Biotherapeutics's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was $6.59. Atara Biotherapeutics's Cyclically Adjusted PB Ratio for today is 0.09.

The historical rank and industry rank for Atara Biotherapeutics's Cyclically Adjusted PB Ratio or its related term are showing as below:

LTS:0HIY' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.04   Med: 0.23   Max: 0.78
Current: 0.09

During the past years, Atara Biotherapeutics's highest Cyclically Adjusted PB Ratio was 0.78. The lowest was 0.04. And the median was 0.23.

LTS:0HIY's Cyclically Adjusted PB Ratio is ranked better than
89.8% of 647 companies
in the Biotechnology industry
Industry Median: 1.75 vs LTS:0HIY: 0.09

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Atara Biotherapeutics's adjusted book value per share data for the three months ended in Mar. 2024 was $-0.817. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $6.59 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Atara Biotherapeutics Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Atara Biotherapeutics's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Atara Biotherapeutics Cyclically Adjusted PB Ratio Chart

Atara Biotherapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 0.49 0.08

Atara Biotherapeutics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.43 0.24 0.23 0.08 0.11

Competitive Comparison of Atara Biotherapeutics's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Atara Biotherapeutics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Atara Biotherapeutics's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Atara Biotherapeutics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Atara Biotherapeutics's Cyclically Adjusted PB Ratio falls into.



Atara Biotherapeutics Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Atara Biotherapeutics's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=0.62/6.59
=0.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Atara Biotherapeutics's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Atara Biotherapeutics's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.817/131.7762*131.7762
=-0.817

Current CPI (Mar. 2024) = 131.7762.

Atara Biotherapeutics Quarterly Data

Book Value per Share CPI Adj_Book
201406 2.898 100.560 3.798
201409 -1.187 100.428 -1.558
201412 5.240 99.070 6.970
201503 6.946 99.621 9.188
201506 6.180 100.684 8.088
201509 11.782 100.392 15.465
201512 11.072 99.792 14.621
201603 10.630 100.470 13.942
201606 10.111 101.688 13.103
201609 9.368 101.861 12.119
201612 8.770 101.863 11.345
201703 8.009 102.862 10.260
201706 7.395 103.349 9.429
201709 6.731 104.136 8.518
201712 5.788 104.011 7.333
201803 10.006 105.290 12.523
201806 9.981 106.317 12.371
201809 8.830 106.507 10.925
201812 7.374 105.998 9.167
201903 6.132 107.251 7.534
201906 4.954 108.070 6.041
201909 5.883 108.329 7.156
201912 5.119 108.420 6.222
202003 4.289 108.902 5.190
202006 5.129 108.767 6.214
202009 4.583 109.815 5.500
202012 5.545 109.897 6.649
202103 4.746 111.754 5.596
202106 3.912 114.631 4.497
202109 3.509 115.734 3.995
202112 3.050 117.630 3.417
202203 2.402 121.301 2.609
202206 2.729 125.017 2.877
202209 1.972 125.227 2.075
202212 1.320 125.222 1.389
202303 0.673 127.348 0.696
202306 0.074 128.729 0.076
202309 -0.499 129.860 -0.506
202312 -0.932 129.419 -0.949
202403 -0.817 131.776 -0.817

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Atara Biotherapeutics  (LTS:0HIY) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Atara Biotherapeutics Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Atara Biotherapeutics's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Atara Biotherapeutics (LTS:0HIY) Business Description

Traded in Other Exchanges
Address
2380 Conejo Spectrum St, Suite 200, Thousand Oaks, CA, USA, 91320
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).

Atara Biotherapeutics (LTS:0HIY) Headlines

No Headlines